Delivered as a Hybrid Event
In Person: Week of November 8, 2021Virtual: Week of November 15, 2021Delivered as a Hybrid Event
In Person: Week of November 8, 2021,
Virtual: Week of November 15, 2021
Stay on the Pulse of Federal and State Reporting Requirements, Policy Initiatives & Strategic Best Practices for Compliance
Discuss how current and future drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Assess how companies are planning internally for these changes, hear updates post-election impacting drug pricing transparency and gain a preview of what’s to come in 2022.
Who Should Attend
You will benefit from attending this event if you are in the pharmaceutical, medical device, or biotechnology industries with responsibilities or involvement in the following areas:
Pricing
Compliance
Strategy Analyst
Reimbursement
Contracting
State/Transparency Reporting
Legal / Counsel
Market Access
Government Affairs
Government Pricing/Programs/Compliance
Commercial Operations
National/Strategic/Corporate Accounts
Managed Care/Markets
Corporate Communications
This conference will also benefit consultants, technology vendors and companies providing services to the above audience.
Connect and Network with Key Decision-Makers at Drug Pricing Transparency
Whether you’re looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.
For more information about custom opportunities to reach a qualified audience, please contact us here.
Get the latest event updates
Sign up to get the latest event updates and information.